Opioid use disorder medication prescribing resources

Background information on the opioid epidemic and recommendations for evaluating opioid use disorder for providers, clients and the interested general public

Prescribing assistance for providers, patients, and the interested general public to increase the effectiveness and safety of medications for opioid use disorder in the ambulatory care setting.

Prescribing assistance for providers, patients, and the interested general public on direct to inject buprenorphine initiations. Direct to inject refers to initiating buprenorphine long-acting injectables without an initial dose of buprenorphine sublingual.

Clinical considerations in special populations of people experiencing an opioid use disorder including co-occurring disorders, older adults, adolescents, pregnancy/lactation, individuals in the criminal justice system, liver impairment, and kidney impairment

Prescribing assistance to increase the effectiveness and safety of naloxone in the ambulatory care setting for providers, patients and the interested general public

References that support the recommendations for treating opioid use disorder for providers, clients and the interested general public

Recommendations for providers in OTPs on the management of methadone for people using fentanyl. Topics include methadone dosing, dosing considerations for clinic absences, approach to take home bottles, EKG monitoring, dosing considerations in pregnant patients and transitions from methadone to buprenorphine.

Introductory pamphlet for buprenorphine traditional start.

Introductory pamphlet for buprenorphine macrodosing.

Introductory pamphlet for buprenorphine microdosing.

Introductory pamphlet for methadone treatment.